India’s Shift to High-Value, Innovation-Led Pharma: Spotlight on GLP-1
India’s GLP-1 market opened up almost overnight. Semaglutide came off patent in March 2026, and multiple Indian manufacturers launched generics […]
India’s GLP-1 market opened up almost overnight. Semaglutide came off patent in March 2026, and multiple Indian manufacturers launched generics […]
The value of India’s medical tourism industry shows an increase from USD 20.4 billion in 2026 to USD 65.1 billion […]
Healthcare is entering a phase in which diagnostics are no longer just a back-end function. It is becoming the intelligence […]
For generations, obesity in India was managed the same way: with advice that placed the entire burden on the individual. […]
Healthcare has always been constrained by time. In diagnostics, delays are not just operational inefficiencies; they directly affect clinical outcomes, […]
As healthcare rapidly adopts AI, concerns around accuracy, safety, and trust have become impossible to ignore, especially in patient-facing applications. […]
Across the world, countless families care for loved ones who can’t easily communicate when something is wrong. From nonverbal autistic […]
For most patients, healthcare is decided in a single moment; not by a report or a prescription, but by whether […]
India’s eye care landscape, since the last decade, has been undergoing a significant shift, with laser vision correction emerging as […]
When connectivity in hospitals is discussed, the focus is often on systems and infrastructure. But for patients and their families, […]
In document-intensive fields such as healthcare and pharmaceuticals, the speed and accuracy of data extraction are critical for patient safety […]
In an era where preventive healthcare is gaining momentum, microbiome science is emerging as a powerful frontier in personalizing wellness. […]
On February 28, 2026, the global pharmaceutical landscape underwent a fundamental structural realignment. The escalation of the US-Israel-Iran conflict has […]